Healthcare-Associated Central Nervous System Infections



Healthcare-Associated Central Nervous System Infections


Jeffrey M. Tessier

W. Michael Scheld



Healthcare-associated infections related to the central nervous system (CNS) are a relatively infrequent but important category of hospital-acquired infections. These infections span a spectrum from superficial wound infections, to ventricular shunt infections, to deep-seated abscesses of the brain parenchyma. The patient populations affected are equally diverse, involving neonates, children, and adults, with occurrence on nearly all medical and surgical services.

Healthcare-associated infections of the CNS are usually serious, if not life threatening, and are frequently associated with a poor outcome (1, 2, 3 and 4,5,6, 7, 8, 9, 10, 11, 12 and 13). These healthcare-associated infections present many challenges in diagnosis, and many controversies exist regarding effective prophylaxis and proper management. In addition, the identification of a particular infection as healthcare-associated may not be clear-cut; thus, overlaps and ambiguities concerning acquisition are unavoidable. Fortunately, a heightened awareness has fostered declining rates of infection. In spite of improving techniques and new preventive strategies, the threat is constant, and the stakes remain painfully high. The first part of this chapter focuses on the clinical and epidemiologic aspects of infections related directly to neurosurgical and neuroinvasive procedures as well as infectious processes that invade the CNS secondarily from other sites. The second part of this chapter discusses prevention and control of these infections.


RISK FACTORS


General Risk Factors

Not surprisingly, the patients at greatest risk for acquiring healthcare-associated CNS infections are neurosurgical patients. Patients with surgical site infections (SSIs) are drawn almost entirely from this population. These patients are subjected to procedures that traverse the scalp, violate meningeal coverings, impinge upon the paranasal sinuses, implant foreign bodies, and expose tissues to hematogenous sources of infection. Infection in this setting is often facilitated by the presence of a cerebrospinal fluid (CSF) leak that occurs when the dura is disrupted and the subarachnoid space communicates with the skin, nasal cavity, paranasal sinuses, or middle ear (14, 15, 16, 17, 18 and 19). This group includes adult and pediatric patients undergoing common neurosurgical and neuroinvasive procedures such as craniotomy, spinal fusion, laminectomy, insertion of halo pins, burr hole placement, and implantation of ventricular shunts and reservoirs. Less common procedures include stereotactic brain biopsy, hypophysectomy, paranasal sinus surgery, acoustic neuroma resection, temporary ventricular drainage, placement of intracranial monitoring devices, nerve stimulator placement, lumbar puncture, spinal anesthesia, myelography, and skull/spinal fixation.

Patients who have suffered accidental head trauma are another population at increased risk to develop meningitis. These individuals have sustained trauma or fractures to the basilar skull and facial bones, facilitating the formation of a CSF fistula. This posttraumatic condition substantially increases the likelihood of CNS infection, particularly bacterial meningitis (20, 21 and 22). In one series, a CSF leak was a predisposing factor in approximately 9% of cases of healthcare-associated bacterial meningitis (5).

The majority of healthcare-associated CNS infections reported from the National Nosocomial Infections Surveillance (NNIS) system at the Centers for Disease Control and Prevention (CDC) occurred in newborn nurseries and on surgical services (Table 27-1). All other hospital services account for a small but still substantial number of cases. Patients from this smaller population generally have a parameningeal source of infection that is either contiguous (e.g., sinusitis) or occult (e.g., unsuspected CSF leak), reactivation of latent infection, or an infection that has hematogenously seeded the CNS from a distant site. Patients with malignancies (especially lymphoma and leukemia), organ transplants, and other immunocompromised hosts frequently fall into this last category.

Risk factors for SSIs can be classified into host factors and surgical factors. Examples of host factors include age, sex, American Society of Anesthesiologists (ASA) physical status classification, underlying diseases such as diabetes mellitus, nutritional status, presence of other remote infections, and duration of preoperative stay. Surgical factors include whether the procedure was emergent or elective, hair removal technique, surgeon, use of perioperative antibiotics, duration of surgery, type of operation, site of surgery, and whether gloves were punctured (23) (see Chapter 21 on SSIs.) One study showed that when
patients underwent a neurosurgical procedure, the presence of a postoperative CSF leak was associated with a 13-fold increase in the infection risk (24). Also, a non-CNS concurrent infection increased the infection risk six times, whereas use of perioperative antibiotics was associated with a decrease in the infection rate of about 20%. Three other risk factors—paranasal sinus entry, placement of a foreign body, and use of postoperative drains—were associated with an increased risk of infection, although these associations were not statistically significant. Factors not associated with an increased risk of infection included obesity, surgical reexploration, use of the operative microscope, steroid administration, and acute therapy for seizures. Length of surgery was also not a factor associated with an increased risk of infection. A prospective study of postoperative neurosurgical infections demonstrated a validated five-category classification system for neurosurgical infections based on specific definitions. It found that infection rates were highest for contaminated cases (contamination known to occur, 9.7%), followed by dirty cases (established sepsis at the time of surgery, 9.1%), clean-contaminated (risk of contamination of operative site during surgery, 6.8%), clean with temporary or permanent foreign body (6.0%), and clean (no identifiable risk factors present, 2.6%). In this study, surgery lasting longer than 4 hours was associated with an infection rate of 13.4% (25).








TABLE 27-1 Healthcare-Associated CNS Infections by Hospital Service in NNIS Hospitals 1986 to 1992










































































Percentage of Total Infections


Service


Meningitis


Intracranial


Spinal Abscess


Neurosurgery


43


60


14


High-risk nursery


23


13


0


Well-baby nursery


10


2


0


Medicine


7


6


29


Pediatrics


5


2


14


Surgery


3


6


14


Bum/trauma


3


4


0


Oncology


2


6


0


Orthopedics


1


0


0


OB/GYN


1


0


14


Cardiac surgery


<1


0


14


Total


100


100


100


NNIS, National Nosocomial Infections Surveillance system. (Source: Centers for Disease Control and Prevention/NNIS.)


In addition to neonates (see Chapter 52) and patients undergoing neurosurgery, patients undergoing invasive diagnostic or therapeutic procedures that penetrate the CNS are at risk for developing a healthcare-associated CNS infection (see Section VIII). A subgroup of neurosurgery patients at high risk for healthcare-associated CNS infections includes those with ventricular shunts. Since most shunt infections (70%) have an onset within 2 months of surgery, it is likely that the infecting microorganism is introduced during surgery or in the postoperative period (10). Risk factors for shunt infections are discussed in Chapters 49 and 65. The rate of infection varies with the neurosurgeon (26,27). The efficacy of prophylactic antibiotics in preventing shunt infection is controversial and is discussed below (see Prevention). Patients undergoing diagnostic or therapeutic procedures that penetrate the CNS, such as the installation of dyes or drugs, are more likely to develop healthcare-associated meningitis (28). Although such infections occur infrequently in the present era, they should be considered in the appropriate setting.


Device-Related Risk Factors

Infection is a well-recognized complication of ventriculostomy catheters used for monitoring and drainage (29). Aucoin et al. (30) noted that the rate of infection was associated with the type of monitor used. The lowest infection rate was associated with the subarachnoid screw (7.5%), followed by a rate of 14.9% for the subdural cup catheter and a 21.9% rate for the ventriculostomy catheter. An intracranial monitoring technique, the Camino intraparenchymal fiberoptic catheter system, is associated with an infection rate of 2.5% (31). The method of ventriculostomy insertion using the tunneled technique has been associated with the lowest rates of infection (29). Use of prophylactic antibiotics did not reduce significantly the risk of infection. In a study by Mayhall et al. (9) of ventriculostomy-related infections, risk factors significantly associated with infection included an intracerebral hemorrhage with intraventricular hemorrhage, a neurosurgical operation, ICP of 20 mm Hg or higher, ventricular catheterization for longer than 5 days, and irrigation of the system. The incidence of infection was not related to insertion location when the intensive care unit was compared with the operating room. Infection rates were also not reduced by the use of nafcillin prophylaxis. Several additional studies have confirmed the direct relationship between the duration of ventricular catheters and infection risk (32, 33, 34, 35 and 36). Additional risk factors associated with ventriculitis include sepsis, pneumonia, urinary tract infection, depressed skull fracture requiring surgery, craniotomy, CSF leakage around the device, drain blockage, reinsertion related to catheter malfunction, and intraventricular hemorrhage. To reduce the risk of ICP monitor-related infections, it is recommended that the device be inserted using aseptic technique, that the device be removed as soon as possible and preferably before 5 days, and that a closed system be maintained. A randomized, controlled trial of external ventricular drainassociated infection compared regular exchange of the drain every 5 days with clinically indicated exchanges and found no difference in the rate of infection between these groups (37). The use of prophylactic catheter exchange and extending the duration of catheterization to 10 days has been proposed, but more data are needed (29). The type of ICP monitor device used influences the rate of infection, with epidural tunneled monitors having the lowest rates.


SOURCES OF INFECTION


Sources of Infecting Microorganisms

Nonsurgical Infections Healthcare-associated CNS infections can be classified into those infections unrelated to surgery and postsurgical infections. In patients with
nonsurgical-related infections, the microorganisms can compose a patient’s endogenous flora, such as coagulasenegative staphylococci (CoNS), or arise from an exogenous source, such as from a contaminated solution or device (28). Gram-negative bacilli are usually responsible for infections related to contaminated solutions or devices (38). Microorganisms can gain access to the CSF by hematogenous spreading of an infectious agent, spread to the CSF from contiguous foci, such as an infected sinus, or via a communication of the CSF with the flora of the skin, sinuses, or other mucosal surfaces (39,40). CSF leakage can be obvious in a patient with rhinorrhea or otorrhea, or occult if the subarachnoid space communicates with a paranasal sinus. Rarely, neoplasms erode into the subarachnoid space and produce a fistula. Microorganisms can also gain access to the CSF by direct inoculation of the agent in a patient having a lumbar puncture, especially if a substance is injected. Microorganisms acquired in this manner are usually gramnegative rods (41,42). It is extremely unusual to develop meningitis following a lumbar puncture unless a solution is injected into the CSF.

Infection is a well-recognized complication of chronic epidural catheters and intracerebroventricular devices (43) used for control of pain in patients with AIDS or malignancy (44) (see Chapter 60). Hayek et al. studied patients with noncancer pain and found a higher infection rate (5.51 infections per 1,000 catheter-days) among patients using tunneled epidural catheters (TECs) for neuropathic pain compared to those with TECs used to treat somatic pain (2.43 infections per 1,000 catheter-days) (45). Staphylococci accounted for 11 of 23 positive epidural space or catheter tip cultures, supporting the hypothesis that most of the TEC infections were due to skin flora migration and colonization of these catheters. Other complications include meningitis and epidural abscess, but prolonged surgery during catheter placement has been found to be the only factor associated with catheter infection (46). Infection may also complicate the use of an Ommaya reservoir (47). Repeated access of these devices may permit colonizing skin flora such as Staphylococcus aureus, S. epidermidis, or diphtheroids to produce ventriculitis and meningitis. The source of the infecting microorganisms may also be the hands of the hospital personnel accessing the device, although powder contamination from gloves has also been implicated (48).

Neurosurgical Infections Although many sources of contamination of a neurosurgical operation have been described, it is usually impossible to document with certainty the source for a given SSI. Probably most infections occur at the time of surgery from either direct inoculation of residual flora of the patient’s skin or from contiguous spread from infected host tissue. Direct inoculation of microorganisms can also occur occasionally from the hands of surgical team members via a tear in a glove. Rarely, the source of infection is traced to contaminated surgical material such as a solution, device, or instrument. In two neurosurgical patients with postoperative Bacillus cereus meningitis, the source of the microorganisms was found to be heavily contaminated linen (49). Occasionally, during the postoperative period, an SSI results from direct inoculation of microorganisms. Airborne contamination at the time of surgery, either from the patient or from operating room personnel, accounts for some neurosurgical infections (1,50). Lastly, a postoperative infection rarely results from hematogenous seeding of a wound from an infected intravenous line or other remote infection.

Outbreaks of neurosurgical infections occur infrequently today, and when they have been described, they have occurred mainly in hospitalized neonates (51, 52 and 53).


INCIDENCE AND DISTRIBUTION

Healthcare-associated infections of the CNS (excluding wound or SSIs) are relatively uncommon, accounting for approximately 0.4% of all healthcare-associated infections (R. Gaynes, personal communication to Nelson Gantz). Meningitis accounts for 91% of these infections, followed by intracranial suppurations (8%) and isolated spinal abscess (1%) (R. Gaynes, personal communication to Nelson Gantz). When infection rates are examined using data reported from 163 hospitals participating in the NNIS system, 0.56 CNS infections per 10,000 hospital discharges occurred from 1986 through early 1993 (R. Gaynes, personal communication to Nelson Gantz). Comparable rates over the past 25 years have shown a slow decline from approximately one infection per 10,000 hospital discharges to the present lower rate (54). While these numbers are relatively small, it must be noted that CNS infections directly related to neurosurgical procedures (SSIs) are not reflected in these numbers. The majority of healthcare-associated CNS infections occurring in this setting are designated under the larger category of SSIs (22% of all healthcare-associated infections) by the CDC National Healthcare Safety Network (NHSN) system surveillance criteria (see below) (401). Certain healthcare-associated CNS infections may represent a greater proportion of specific types of infection. For example, a retrospective study of acute bacterial meningitis in adults over a 27-year period at the Massachusetts General Hospital found 40% of 493 total episodes to be healthcareassociated in origin (5).

Healthcare-associated surgical site and CSF infections among neurosurgical patients are a primary focus of this chapter. Table 27-2 shows the distribution of SSIs complicating neurosurgical procedures and illustrates the significant proportion of deep infections that occur in relation to the surgical site; these data are derived from the NNIS reporting period 1986-1992. Infection rates as reported in the general neurosurgical literature are often difficult to interpret and compare for a variety of reasons, including differences in definitions, methodology, reporting techniques, and use of prophylactic antibiotics. Not uncommonly, postoperative infections unrelated to the surgical site or CNS are included in the rate calculation (2). An overview of infection rates associated with neurosurgery from some of the more rigorously performed (although nonstandardized) studies over the last 30 years is shown in Table 27-3. Taking into account some of the problems mentioned above, most hospital series report infection rates of <5%. When individual neurosurgical procedures are compared, differences in infection rate become more apparent. The incidence of all CNS infection following typically clean craniotomy may vary from <1% to nearly 9%,
whereas the rates following laminectomy range from 0.6% to 5%. Postoperative meningitis after clean craniotomy has a reported incidence of 0.5% to 2% when perioperative antibiotics are given (55,56,72, 73 and 74). Without antibiotic prophylaxis, other studies have found rates ranging from 2% to 7% (74, 75 and 76). A more recent large prospective study of infections after craniotomy among 2,944 patients found an overall SSI rate of 4%, with meningitis representing approximately 48% of these infections (77).








TABLE 27-2 Surgical Site Infections Following Neurosurgical Procedures

























































































Surgical Site


Procedure


Men


SA


SSI


DSI


IC


IAB


Bone


Disc


Other


Total


Craniotomy (n = 191)a


22%



60%


2%


12%





4%


100%


Laminectomy (n = 615)


1%


3%


75%


11%




4%


6%



100%


Ventricular shunt (n = 93)


76%



18%




4%




2%


100%


Head and neck (n = 324)


3%



77%


13%




2%



5%


100%


Miscellaneous (n = 49)


8%


2%


82%




8%





100%


Data from Refs. (55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70 and 71).


a Number of operations performed.


Men, meningitis; SA, spinal abscess; SSI, superficial surgical site infection; DSI, deep surgical site/soft tissue infection; IC, intracranial infection; IAB, intra-abdominal abscess; bone, osteomyelitis; disc, discitis.


(Source: CDC/NNIS.)


Infection rates for selected neuroinvasive procedures are shown in Table 27-4. Again, differences in methodology, definition, and duration of follow-up greatly affect the reported rates. Analysis of infection rates following ventricular shunt surgery is particularly complex. Depending on the use of a case rate (occurrence per patient) or an operative rate (occurrence per procedure) of infection and the duration of follow-up, an extremely wide variation in incidence may be seen. Perhaps, when in 1916 Cushing (107) stated, “There has never been any infection, even of a stitch in the scalp, in something over 300 cranial operations in the writer’s series,” he underestimated the situation. A procedure-oriented risk factor analysis is covered in a later section, and additional details are discussed elsewhere in this text (see Chapters 49, 60, and 65).








TABLE 27-3 Infection Rates in Selected Neurosurgery Trials





































































































































































Series (year)


All Procedures


%


Laminectomy


%


Craniotomy


%


Odum (1962)




3,774


0.6


2,342


1.3


Cairns (1963)






1,169


4.4


Wright (1966)




2,085


4.1


2,148


5.7


Green (1974)


1,770


2.3


529


2.3


692


2.6


Savitz (1974)


495


3.6


239


3.8


214


4.2


El-Gindi (1965)




650


0.8


Madeja (1977)


1,129


3.8


Quadery (1977)


357


4.8


40


5.0


144


5.7


Haines (1982)


1,663


1.7


Lindholm (1982)




3,576


0.8


Chan (1984)






338


4.7


Jomin (1984)






500


3.0


Puranen (1984)




1,100


0.7


Blomstedt (1985)


1,039


5.7




622


8.0


Tenney (1985)


936


5.5




494


7.3


Savitz (1986)






872


0.2


Ingham (1988)






1,167


3.3


Cartmill (1989)


423


0.7


Winston (1992)






312


0.3


Holloway (1996)


560


0.5


Korinek (1997)






2,944


4.0


Zhu (2001)


180


2.8


Whitby (2000)


780


6.9










TABLE 27-4 Infection Rates in Selected Neuroinvasive Procedures












































Procedure


Infection Rate


Ventricular shunt



Operative


3-13%



Case


9-41%


Cerebrospinal fluid reservoir


4-23%


Ventriculostomya


0-11%


Burr hole


1-5%


Spinal anesthesia


<0.5%


Lumbar puncture


<2%


Epidural catheter


0-4%


Stereotactic biopsy


<1%


Myelography


Rare


(Data from Refs. 9,10,30,44,60,62,78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105 and 106,409.)


a Includes external drainage and intracranial pressure monitoring devices.


Examination of SSIs reported from NNIS system hospitals between 1992 and 2004 shows infection rates in uncomplicated procedures with minimum risk factors to be 0.91/100 operations for craniotomies, 1.04/100 operations for spinal fusion, 0.88/100 operations for laminectomies, and 4.42/100 operations for ventricular shunts (108) The last rate is the third highest among all operative procedures (108). These surveillance rates, by definition, include both superficial and deep infections related to the operative site (109,110). The addition of one or more complications (surgical risk factors) will increase most of the figures to varying degrees (111).

The incidence of both community- and hospital-acquired CNS infections in immunocompromised hosts has been estimated to range from <1% to over 10%, depending on the host population (112, 113, 114 and 115). Classic studies at the Memorial Sloan-Kettering Cancer Center in the early 1970s revealed an incidence of CNS infections approximating 0.02% of total hospitalizations (116). These infections occurred most commonly in lymphoma patients (33%), followed by neurosurgical patients (30%) and leukemic patients (20%). Overall, meningitis accounted for the majority of infections (71%), followed by brain abscess (27%) and encephalitis (2%). Of note, intracerebral abscess in leukemic patients was responsible for 70% of CNS infections in this group. It has been postulated that conventional incidence figures may significantly underestimate the actual magnitude of CNS infections in this population (112). Other studies have shown similar patterns in cancer patients, with perhaps a higher incidence of CNS infection in transplant recipients estimated at 5% to 12% (114,115). One retrospective study of bone marrow transplant recipients found symptomatic neurologic complications, predominantly infectious (23% of complications), among 16% of patients (117). CNS infections were more common among allogeneic compared to autologous transplants and included cerebral toxoplasmosis, viral encephalitis, and fungal infections. Brain abscess was found to be a common complication in one study of heart and heart-lung transplant recipients, accounting for 35% to 44% of CNS infections (113,118). These abscesses are often caused by fungi, particularly Aspergillus species, among liver transplant recipients (119). Bacterial meningitis in the febrile neutropenic patient is often indolent in presentation and masked by the early use of broad-spectrum antibiotics. Disseminated fungal infections are not uncommon in the compromised host and are frequently difficult to diagnose; Candida is reported to involve the CNS in up to 50% of cases (120,121). Although the absolute number of healthcare-associated infections in this population cannot easily be determined, the proportion is likely to be high, as many occur after multiple or prolonged hospitalizations and are caused by typical healthcare-associated pathogens.


TYPES OF HEALTHCARE-ASSOCIATED CENTRAL NERVOUS SYSTEM INFECTIONS

Healthcare-associated infections related to the CNS may be broadly divided into two major categories (Table 27-5): postsurgical infections and nonsurgical infections, including those related to neuroinvasive or neurodiagnostic procedures. The first category consists of SSIs (109). Infections of this type may occur following craniotomy, ventriculostomy, and spinal column surgery. Rarely, SSIs complicate other neurosurgical operations, such as peripheral nerve surgery and carotid endarterectomy. SSIs are further classified as superficial or deep incisional SSIs, using the fascial plane as divider. Deep surgical infections unrelated to soft tissues are classified as organ/space SSIs by the aforementioned CDC criteria (109). These infections may present as a local and/or diffuse infectious process. Local suppurative infections complicating neurosurgical procedures include the following: parenchymal brain abscess, subdural empyema, epidural abscess,
discitis, subgaleal collection, and osteomyelitis of the cranium or spine. Diffuse infection of the subarachnoid space defines meningitis or ventriculitis if the process is related to a prior ventriculostomy and essentially remains localized. This latter distinction is somewhat arbitrary. Meningoencephalitis is an infrequent diffuse healthcareassociated CNS infection generally due to prions or viruses transferred during neuroinvasive procedures or via organ transplantation (122, 123, 124, 125, 126, 127 and 128).








TABLE 27-5 Healthcare-Associated CNS Infections





























































Postsurgical


Nonsurgical


Surgical site infections


Contiguous focus or hematogenous



Superficial incisional



Epidural abscess



Deep incisional



Subdural empyema


Organ/space infections



Brain abscess


Local suppurative



Meningitis



infections



Meningoencephalitis



Osteomyelitis



Discitis



Subgaleal collection



Epidural abscess



Subdural empyema



Brain abscess


Diffuse infections



Meningitis



Ventriculitis



Meningoencephalitis


Nonsurgical infections constitute a smaller, but equally important, class of healthcare-associated CNS infections. These infections are acquired by a variety of routes that include spread from a contiguous focus, posttraumatic/CSF leak, and neuroinvasive procedures, as well as hematogenous spread. Meningitis, brain abscess, subdural empyema, and epidural abscess all may occur in this setting.




CEREBROSPINAL FLUID SHUNT INFECTIONS

A variety of temporary and permanent prosthetic devices are used to access, drain, divert, and monitor the CSF. These devices may be internalized for chronic use or externalized for use in the acute setting. Internalized devices consist of shunts (ventriculoperitoneal, ventriculoatrial, ventriculoureteral, lumboperitoneal), and reservoirs (lumbar, ventricular). Externalized devices facilitate drainage (ventriculostomy, lumbar drain, external shunt) or measure ICP when the device (intraventricular, epidural, subdural) is connected to a transducer. Insertion of a ventriculoperitoneal shunt is the most common surgical procedure performed for the long-term control of hydrocephalus. Infections complicating these devices may occur at any site or compartment traversed by the prosthesis. Proximal infections include meningitis, ventriculitis, empyema, abscess, and infection involving the surgical site (wound infection, cellulitis, osteomyelitis). Distal infections include tunnel infections along the catheter tract, bacteremia, pleuritis, peritonitis, and related intra-abdominal infections. Infections of temporary devices are almost always healthcare associated, because their insertion and use requires hospitalization. The current CDC guidelines define infection secondary to an implantable device as healthcare associated if it occurs within 1 year of the operative procedure and the two appear to be related (109). Such a designation must often be based subjectively on the type of infection, clinical setting, and responsible microorganism. Because of the clustering of shunt infections within 60 days of implantation (10,64,79,80,202,203), shorter periods have been suggested to designate a shunt infection as healthcare associated (129). Because of the considerable overlap among infections of different CNS prosthetic devices, this discussion can focus on the diagnosis of CSF shunt infections as the prototype for this group. Certain specific infections potentially related to CSF shunts have already been covered in detail earlier in this chapter (SSIs) or are covered in later sections (intracranial suppurations).

The most important risk factor for the development of CNS shunt infection is the level of training of the neurosurgeon, with neurosurgical trainees having a higher rate of infection (27). Variables such as year of placement of the shunt, age of the patient, length and time of the operation, and exact placement of the distal drain do not increase the risk of infection (202,204). Additionally, elevated CSF protein content does not appear to increase the risk of shunt infection (205).

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 22, 2016 | Posted by in GENERAL & FAMILY MEDICINE | Comments Off on Healthcare-Associated Central Nervous System Infections

Full access? Get Clinical Tree

Get Clinical Tree app for offline access